BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 12668976)

  • 1. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
    Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
    Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration.
    Albrecht JH; Meyer AH; Hu MY
    Hepatology; 1997 Mar; 25(3):557-63. PubMed ID: 9049198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
    J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH
    Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclin D-dependent kinase activity in rat liver regeneration.
    Kato A; Ota S; Bamba H; Wong RM; Ohmura E; Imai Y; Matsuzaki F
    Biochem Biophys Res Commun; 1998 Apr; 245(1):70-4. PubMed ID: 9535785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions.
    McIntyre M; Desdouets C; Sénamaud-Beaufort C; Laurent-Winter C; Lamas E; Bréchot C
    Oncogene; 1999 Aug; 18(32):4577-85. PubMed ID: 10467402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS
    Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of positive and negative regulators of cell cycle during wound healing.
    Zhu X; Di Y; Hu C; Wang Z
    Chin Med J (Engl); 2002 Mar; 115(3):326-30. PubMed ID: 11940356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of protein kinase C promotes human cancer cell growth through downregulation of p18(INK4c).
    Matsuzaki Y; Takaoka Y; Hitomi T; Nishino H; Sakai T
    Oncogene; 2004 Jul; 23(31):5409-14. PubMed ID: 15107819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
    LaRue KE; Bradbury EM; Freyer JP
    Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
    J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of in vivo rat liver regeneration by 2-acetylaminofluorene affects the regulation of cell cycle-related proteins.
    Ohlson LC; Koroxenidou L; Hällström IP
    Hepatology; 1998 Mar; 27(3):691-6. PubMed ID: 9500696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
    Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
    EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
    Damo LA; Snyder PW; Franklin DS
    Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.